Phibro Animal Health (PAHC) Net Income towards Common Stockholders (QoQ) (2012 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Net Income towards Common Stockholders (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.63% |
| Mar 31, 2026 | -12.51% |
| Dec 31, 2025 | 3.51% |
| Sep 30, 2025 | 112.71% |
| Jun 30, 2025 | -40.27% |
| Mar 31, 2025 | 555.57% |
| Dec 31, 2024 | -54.34% |
| Sep 30, 2024 | -39.75% |
| Jun 30, 2024 | 37.74% |
| Mar 31, 2024 | 559.73% |
| Dec 31, 2023 | 115.90% |
| Sep 30, 2023 | -193.18% |
| Jun 30, 2023 | -14.34% |
| Mar 31, 2023 | 39.28% |
| Dec 31, 2022 | 86.98% |
| Sep 30, 2022 | -42.31% |
| Jun 30, 2022 | -62.21% |
| Mar 31, 2022 | 1.28% |
| Dec 31, 2021 | 167.29% |
| Sep 30, 2021 | -56.26% |